1. Hippocampal function, declarative memory, and schizophrenia: Anatomic and functional neuroimaging considerations

   • Alison R. Preston
   • Daphna Shohamy
   • Anthony D. Wagner

   Invited Commentary Pages: 249 - 256

2. Web alert

   News Pages: 257 - 258

3. Levodopa and the progression of Parkinson’s disease

   • John Morgan
   • Kapil D. Sethi

   Clinical Trials Report Pages: 261 - 262

4. Rivastigmine for dementia associated with Parkinson’s disease

   • John Morgan
   • Kapil D. Sethi

   Clinical Trials Report Pages: 263 - 265

5. Restless legs syndrome

   • William G. Ondo

   OriginalPaper Pages: 266 - 274

6. The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential

   • K. Ray Chaudhuri
   • L. Yates
   • P. Martinez-Martin

   OriginalPaper Pages: 275 - 283

7. Movement disorder emergencies

   • Steven J. Frucht

   OriginalPaper Pages: 284 - 293

8. Sleep disturbances in epilepsy patients

   • Carl W. Bazil

   Clinical Trials Report Pages: 297 - 298

9. Functional magnetic resonance imaging in the treatment of epilepsy

   • Joseph E. Sullivan III
   • John A. Detre

   OriginalPaper Pages: 299 - 306

10. Genetics of drug resistance in epilepsy

    • Sanjay M. Sisodiya

    OriginalPaper Pages: 307 - 311

11. Continuous electroencephalogram monitoring in critically ill patients

    • Nathalie Jette
    • Lawrence J. Hirsch

    OriginalPaper Pages: 312 - 321

12. The use of monotherapy in patients with epilepsy: An appraisal of the new antiepileptic drugs

    • Andres M. Kanner
    • Antoaneta J. Balabanov

    OriginalPaper Pages: 322 - 328